Cargando…

Perfusion CT to evaluate the effect of transluminal angioplasty on cerebral perfusion in the treatment of vasospasm after subarachnoid hemorrhage

INTRODUCTION: Delayed ischemic neurologic deficits secondary to vasospasm are a major cause of morbility and mortality after subarachnoid hemorrhage (SAH). Treatment of vasospasm after SAH is associated with complications, and reliable techniques for evaluating effects of treatment of vasospasm in s...

Descripción completa

Detalles Bibliográficos
Autores principales: Majoie, Charles B. L. M., van Bcven, Leonard J., van de Beek, Diederik, Venema, Henk W., van Rooij, Willem J.
Formato: Texto
Lenguaje:English
Publicado: Humana Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782106/
https://www.ncbi.nlm.nih.gov/pubmed/17356190
http://dx.doi.org/10.1385/NCC:6:1:40
Descripción
Sumario:INTRODUCTION: Delayed ischemic neurologic deficits secondary to vasospasm are a major cause of morbility and mortality after subarachnoid hemorrhage (SAH). Treatment of vasospasm after SAH is associated with complications, and reliable techniques for evaluating effects of treatment of vasospasm in such patients are warranted. We present the use of perfusion computed tomography (PTC) to evaluate the effect of transluminal percutaneous angioplasty in a with SAH and vasospasm-induced ischemiia. METHODS: Dynamic PCT with deconvolution produced maps of time-to-peak, mean transit time, regional cerebral blood flow, and regional cerebral blood volume, with a computerized automated map of the infarct and penumbra. CT scanners with quadruple detector array were used before and after angioplasty. RESULTS: Before angioplasty and intraarterial papaverine, PCT showed normal to decreased cerebral blood flow and increased cerebral blood volume and mean transit time in the middle cerebral artery territory of the left hemisphere. After angioplasty and intraarterial papaverine, PCT showed normalization of perfusion parameters. CONCLUSION: PCT can be a useful technique in monitoring angioplasty treatment effects in patients with vasospasm after SAH.